多功能脂质体基因载体的构建及评价
[Abstract]:The multifunctional liposome is used as a gene vector, and the application of the multifunctional liposome in gene therapy is more and more important, and has a wide application prospect. A multifunctional liposome was constructed by taking folic acid-polyethylene glycol-cholesterol semi-succinate (F-PEG-CHEMS) and stearin 8-poly arginine (R8) as functional components, and taking it as carrier of ASODN and plasmid DNA. To explore the feasibility of the drug delivery system as a gene drug cell. Firstly, the synthesis of cholesterol semi-succinate (CHEMS), polyethylene glycol monomethyl ether-cholesterol semi-succinate (MPEG-CHEMS) and F-PEG-CHEMS was designed based on the literature. The synthesis of F-PEG-CHEMS is carried out by reaction of folic acid with polyethylene glycol diamine (NH2-PEG-NH2). H2 and then reacting cholesterol semi-succinic acid ester (CHEMS) with N-hydroxyamber to prepare the F-CHEMS, and finally reacting the F-PEG-NH2 with the NHS-CHEMS to obtain the F-PEG-NH2. MS. The synthesized and purified products were identified as targets by TLC, IR,. 1H-HMR mass spectrometry and 1H-HMR spectroscopy The synthesized and purified liposome membrane material MPEG-CHEMS and F-PEG-CHEMS have laid the foundation for the preparation of multifunctional liposomes. secondly, preparing the common liposome by a thin film dispersion method and incubating the R8 aqueous solution with the common liposome at 45 DEG C for 1h to prepare R8-modified liposome (R8-Lip), The experimental results show that the particle size and distribution of the liposomes are basically unchanged after R8 is modified, and the zeta potential is changed from -10. 24mV to + 38.. 69mV. When +/-exceeds 4: 1 in R8-Lip/ ASODN complex, ASODN has been fully integrated with R8-Lip to positively charged complex; when R8-Lip is less than 10 & mu; g/ mL, cell survival is greater than 75%; R8-Lip contributes to the uptake of ASODN cells and R8 The concentration of R8 is related to the increase of fluorescence intensity in cells when the mass concentration of R8 is increased from 0.3. m u.g/ mL to 9. 6. m u.g/ mL (+/-increased from 1: 2 to 16: 1); when +/-= 16: 1 in R8-Lip/ ASODN complex, R8 promotes the uptake of ASODN stronger than the commercially available transfection reagent, Lipofectin e2000. After PEGylation modification on R8-Lip surface, promote cell uptake AS In order to further improve the effect of cell uptake, a multifunctional liposome R8-Lip-F was constructed and its physicochemical properties were studied in order to further improve the effect of cell uptake. The results show that the morphology of the liposome is regular. Almost all spherical. R8-Lip-F/ ASODN is completed at +/-16: 1 The cellular uptake and positive rate of the R8-Lip-F/ ASODN complex in 6h increased with the increase in time increases. R8-Lip-F/ ASODN complexes are introduced into the cell by an endocytic pathway, It has an energy-dependent mechanism. Its intracellular mechanism is mainly protein-mediated endocytic and giant cell drinking, and the cellular uptake is due to folic acid. competitive inhibition decreased. The majority of ASODN was distributed in cytoplasm after ASODN was introduced into the cytoplasm. The effect of R8-Lip-F on the uptake of ASODN was lower than that of the transfection reagent which was sold in the city. However, it had little effect on the transfection of plasmid DNA. The transfection efficiency was far from the transfection reagent of the market. mine2000, finally, using DOTAP liposome as the basis, introducing F-PEG-CHEMS and R8 in it, constructing multifunctional cationic liposome R8-DOTAP-F, The results show that R8-DOTAP-F In the R8-DOTAP-F complex, pDNA is present in the R8-DOTAP-F complex with a mass ratio of DOTAP to pDNA or ASODN of 30 (positive/ negative charge ratio or N/ P of about 13: 1). and ASODN are combined completely. R8-DOTAP-F/ ASODN complex has cell intake and yang in 6h According to the modification of the folic acid ligand on the liposome, the cell uptake and transfection effect of the liposome complex can be obviously improved, and the R8 modification on the liposome can further Enhancement of cell transfection and uptake results. R8-Lip-F/ ASODN complexes pass endocytic pathways The intracellular mechanism is primarily a protein-mediated endocytic and macrocellular uptake, and the cellular uptake is due to The competitive inhibition of folic acid decreases. The majority of ASODN after entering the cell is distributed in cells. Almost none of the lysosomes in the nucleus. Compared with the transfection reagent which was sold in the market, R8-DOTAP-F promoted the uptake of ASODN.
【学位授予单位】:浙江工业大学
【学位级别】:硕士
【学位授予年份】:2014
【分类号】:R943
【相似文献】
相关期刊论文 前10条
1 王文喜;代凯;唐岚;;八聚精氨酸修饰的载ASODN脂质体的构建及体外评价[J];浙江工业大学学报;2014年03期
2 ;Depressive Effect of the Antisense Oligonucleotides of C-myc and PCNA on the Proliferation of VSMC[J];South China Journal of Cardiology;2007年04期
3 贾红丽;冯珏;张秀梅;杨阳;李晓东;;脂质体包裹~(99m)Tc-HYNIC-Survivin ASODN的鸟嘌呤含量与启动子位置对显像质量的影响[J];中国医学影像技术;2011年03期
4 刘涛;谢民强;马栋;许熠铭;张宏征;张涛;;FA-MNP-MMP-9-ASODN复合物构建及其分子靶向研究[J];临床耳鼻咽喉头颈外科杂志;2013年11期
5 杨雅莹;易永芬;张晓燕;肖春卫;林晓;周文文;;Effect of MUC2 Antisense Oligodeoxynucleotide on Cell Proliferation,Adhesion,and Proteolytic Enzyme in Human Gastric Carcinoma in vitro[J];Chinese Journal of Cancer Research;2007年04期
6 刘涛;谢民强;许熠铭;张宏征;张涛;;FA-MNP-MMP-9-ASODN纳米复合物对鼻咽癌的体外抑制研究[J];临床耳鼻咽喉头颈外科杂志;2014年09期
7 ;Survivin antisense oligodeoxynucleotide inhibits growth of gastric cancer cells[J];World Journal of Gastroenterology;2004年08期
8 ;Enhanced therapeutic effects for human pancreatic cancer by application K-ras and IGF-IR antisense oligodeoxynucleotides[J];World Journal of Gastroenterology;2008年33期
9 何冬梅,张洹;ENHANCEMENT OF RADIATION-INDUCED APOPTOSIS IN RAJI CELL LINE BY BC1-2 ANTISENSE OLIGODEOXYNUCLEOTIDE[J];Chinese Journal of Cancer Research;2005年02期
10 蔡海东;谯娱;袁雪宇;杨越华;袁世栋;孙明;吕中伟;;PEI-RGD/~(125)I-(α_V) ASODN的制备及其对肝癌HepG2细胞侵袭力的抑制[J];中国肿瘤生物治疗杂志;2009年06期
相关会议论文 前7条
1 邵彦江;张振中;;靶向Lipo/PEI/ASODN复合物的制备及其在荷瘤裸鼠体内的分布[A];第十届中国科协年会论文集(三)[C];2008年
2 张艳华;李佩玲;;脂质体介导的ILK—ASODN抑制卵巢癌细胞增殖的体外实验研究[A];东北三省第四届妇产科学术会议论文汇编[C];2008年
3 ;Effects of survivin siRNA gene on prostate cancer cell lines PC3[A];第十五届全国泌尿外科学术会议论文集[C];2008年
4 蔡海东;谯娱;袁雪宇;;以jetPEI-RGD为载体的~(125)I-(αV)ASODN投递对人肝癌细胞侵袭的抑制作用[A];中华医学会第九次全国核医学学术会议论文摘要汇编[C];2011年
5 程文;荆慧;张久维;;超声介导靶向微泡促进c-myc ASODN在肝癌细胞的表达[A];中华医学会第十次全国超声医学学术会议论文汇编[C];2009年
6 蔡海东;谯娱;袁雪宇;;jetPEI-RGD介导的~(125)I-(αV)ASODN对人HCC细胞生长抑制作用的实验研究[A];中华医学会第九次全国核医学学术会议论文摘要汇编[C];2011年
7 江其生;任建平;王升启;;靶向PAI-1mRNA的新型溶栓反义药物研究[A];第八届全国生化药理学术讨论会暨第七届Servier奖颁奖大会会议摘要集[C];2003年
相关博士学位论文 前7条
1 李斌生;载端粒酶ASODN-t的壳聚糖纳米粒的制备和对肝癌HepG-2细胞的转染[D];中南大学;2007年
2 高凯;c-myb在胶质瘤细胞中的表达及~(125)IUdR-ASODN对C_6胶质瘤细胞增殖的影响[D];中国医科大学;2006年
3 陈志涛;乙酰肝素酶反义寡核苷酸对人肺癌细胞A549侵袭力抑制作用的实验研究[D];山东大学;2011年
4 陈余清;肺癌的Survivin基因表达及其靶向治疗的研究[D];复旦大学;2004年
5 蒋绍博;PCNA反义寡核苷酸对雄激素非依赖性前列腺癌细胞增殖抑制机制的研究[D];山东大学;2005年
6 曹永倩;紫杉醇及survivin反义寡核苷酸对恶性黑色素瘤细胞作用的实验研究[D];山东大学;2010年
7 汪涛;高分化胰腺癌多药耐药机制及靶向逆转的初步研究[D];第三军医大学;2003年
相关硕士学位论文 前10条
1 徐越;脑胶质瘤端粒酶反义寡核苷酸纳米微粒的制备及治疗研究[D];南方医科大学;2008年
2 石群;ASODN逆转人胃腺癌SGC7901/ADM细胞多药耐药的实验研究[D];重庆医科大学;2005年
3 杨敏;MK-ASODN增强绒毛膜癌细胞对5-FU化疗敏感性的研究[D];中南大学;2012年
4 李光辉;PDGFR-αASODN玻璃体内注射对视网膜的毒性作用观察[D];桂林医学院;2014年
5 邓长弓;ASODN转染骨肉瘤细胞对Survivin与VEGF表达的影响[D];重庆医科大学;2008年
6 魏玮;Bcl-2ASODN及bax联合转染增强人宫颈癌Hela细胞放射敏感性的实验研究[D];山东大学;2007年
7 陈涛;PEI介导的PKC-α ASODN对SMMC-7721肝癌细胞的生物学作用[D];暨南大学;2008年
8 顾文东;HIF-1α ASODN对人肺癌裸鼠移植瘤HIF-1α、GLUT-1、MMP-2表达的影响[D];苏州大学;2008年
9 王蕾艳;联合转染VEGF和PCNA-ASODN对实验兔血管成形术后再狭窄的影响[D];山东大学;2011年
10 于芳;反义寡核苷酸抑制LA-N-5细胞VEGF表达及生物效应的研究[D];中国人民解放军军医进修学院;2007年
,本文编号:2283671
本文链接:https://www.wllwen.com/yixuelunwen/yiyaoxuelunwen/2283671.html